6 Although this dispute crystallised and eventually escalated subsequent to November 1998, in reality the battle lines were drawn at that time. The respondents say that the Di-Med Inventions were a new, completely original concept which owed nothing to the Eastland Devices or the Reversyringe. The applicants, on the other hand, say that the Di-Med Inventions grew out of or were developments of the Eastland Devices and Reversyringe. Furthermore, they say that the first respondent as a director of Eastland owed the company fiduciary duties and that by applying for patents in the name of Di-Med and excluding Eastland, the first respondent was breaching those fiduciary duties. As against the second respondent the applicants say that he was relying on their intellectual property in the Eastland Devices and Reversyringe when he developed the Di-Med Inventions. The applicants claim that property in the Di-Med Inventions is theirs. They also accused the first and second respondents of fraud. Without going into detail in relation to this allegation, essentially it is said that the Di-Med Inventions are a direct development of the Eastland Devices, the first and second defendants knew as much when they applied for patents and they intended to deprive Eastland of its proper entitlements.